Levy Y, Durier C, Krzysiek
R, Rabian C, Capitant C, Lascaux AS, Michon C, Oksenhendler E, Weiss L,
Gastaut JA, Goujard C, Rouzioux C, Maral J, Delfraissy JF, Emilie D,
Aboulker JP and the ANRS 079 study group. Effects of
Interleukin-2 therapy combined with highly active antiretroviral therapy
on immune restoration in HIV-1 infection: a randomised controlled
trial. AIDS 2003, 17 : 343-351. Lien PubMed
Litalien C, Faye A, Compagnucci A, Giaquinto C, Harper L, Gibb DM, Jacqz-Aigrain E.Pharmacokinetics
of Nelfinavir ant its active metabolite, hydroxy-tert-butylamide, in
infants perinatally infected with human immunodeficiency virus type 1. Pediatr Infect Dis J 2003, 22 : 48-55. Lien PubMed
Diagbouga
S, Chazallon C, Kazatchkine M, Van de Perre P, Inwoley A, M’Boup S,
Prince David M, Ténin Aoua Thiéro, Soudré R, Aboulker JP, Weiss L.Successful
implementation of a low cost method for enumerating CD4+ T lymphocytes
in resource-limited settings (ANRS 12-26 study). AIDS 2003, 17: 2201-2208.Lien PubMed
Lan
NT, Recordon-Pinson P, Hung PV, Uyen NT, Lien TT, Tien HT, Garrigue I,
Schrive MH, Pellegrin I, Lafon ME, Aboulker JP, Barre-Sinousi F, Fleury
HJ. HIV-1 isolates from 200 untreated individuals in Ho Chi
Minh City (Vietnam) : ANRS 1257 study . Large predominance of CRF01_AE
and presence of major resistance mutations to antiretroviral drugs. AIDS Res Hum Retroviruses 2003, 19:925-28.Lien PubMed